David W. Newton
Mr. Newton is one of our co-founders and has been a Vice President and one of our directors since our inception in 1991. From 1989 until 1991, Mr. Newton was President of Newton Associates, Inc., a contract engineering firm. From 1985 to 1989, Mr. Newton was President of Tienet, Inc., a developer of integrated computer systems. Mr. Newton has an additional 16 years of experience as an electrical engineer designing electrosurgical generators and related accessories. Mr. Newton holds 21 patents in the field of medical electronic equipment and holds a Bachelor of Science Electrical Engineering degree from the University of Colorado.
Mr. Trudel has served on our board of directors as well as our President and CEO since December 2013. Prior to joining Encision, Greg served as Global Director of Marketing for a division within the Surgical Solutions Group at Covidien. His time at Covidien also includes extensive experience in both the Advanced Energy and Surgical Stapling Divisions. Prior to joining Covidien, Greg held leadership roles with ConMed Electrosurgery, SilverGlide Surgical Technologies, and Stryker. He holds a B.S. from the University of Connecticut, Storrs, CT and an M.B.A from the University of Bridgeport, Bridgeport, CT.
Patrick W. Pace, M.D.
Dr. Pace has served on Encision’s board of directors since April 2012, serving as chairman from August 2013 through August 2015. Pat is also a Director on UTIMCO’s Private Markets team, helping manage the endowments’ private markets portfolio. He is also responsible for healthcare investments across the endowments. He joined UTIMCO after serving as an Advisor to EDG Partners, a healthcare private equity firm. Previously, Pat served as Managing Director at Citadel Investment Group and helped launch its effort in investment banking. Prior to Citadel, he led healthcare high yield and distressed debt investing as part of AIG Investments, served as a Senior Analyst covering the medical device industry at UBS, and worked in Equities at Credit Suisse First Boston. Dr. Pace also serves on the board of MMIS, Inc, and as Executive Chairman of Nanospectra Biosciences, a medical device company focusing on the use of nanoparticles in the treatment of a variety of diseases, where he recently led a recapitalization of the company and a change in strategic focus. Dr. Pace began his career as a resident in Otolaryngology (ENT) at the University of Virginia Hospital. He holds a Bachelor of Arts, with Honors in Psychology, from Vanderbilt University and a Doctor of Medicine from The University of Texas Medical School at Houston.
Vern D. Kornelsen
Mr, Kornelsen is one of our co-founders and served on our board of directors and as our Chief Financial Officer from 1991 through February 1997. He was re-elected to the board of directors in April 1998. Mr. Kornelsen is the General Partner of CMED Partners LLLP, one our principal shareholders. Mr. Kornelsen formerly practiced as a certified public accountant in the state of Colorado for many years. For the past nine years, he has been active in managing two investment partnerships, of which he is the general partner, as well as serving as an officer and director of several private companies and of one public company, Lifeloc Technologies, Inc., of which he is the controlling stockholder. Mr. Kornelsen received a Bachelor of Science degree in business from the University of Kansas.